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Abstract: The total synthesis of representative members of the 
Schizozygine alkaloids (+)-vallesamidine and (+)-14,15-
dehydrostrempeliopine were completed from a late stage divergent 
intermediate. The synthesis took advantage of efficient nitro group 
reactions with the A/B/C ring skeleton constructed concisely in gram 
scale through an asymmetric Michael addition, nitro-
Mannich/lactamisation, Tsuji-Trost allylation and intramolecular C-N 
coupling reaction. Other key features of the synthesis are a novel 
[1,4]-hydride transfer/Mannich type cyclisation to build ring E and a 
diastereoselective ring closing metathesis reaction to construct ring D. 
This gave access to a late stage C-14,15 alkene divergent 
intermediate that could be simply transformed into (+)-vallesamidine, 
(+)-14,15-dehydrostrempeliopine and potentially other schizozygine 
alkaloids and unnatural derivatives. 
Introduction 
Vallesamidine (1) and strempeliopine (2) are monoterpene indole 
alkaloids isolated from Vallesia dichotoma Ruiz et Pav[1] and 
Strempeliopsis strempelioides K Schum[2] respectively, and are 
structurally related to similar, but more complex, schizozygine 
alkaloids 3-5[3] that contain an additional C-14,15 alkene and 
oxygenated aromatic cores (Figure 1). Their potential 
bioactivities[4] and highly fused, polycyclic ring skeletons have 
attracted many efforts towards their total synthesis. Currently, the 
total syntheses of schizozygine alkaloids 3-5 have not been 
reported,[5] but the total synthesis of vallesamidine (1)[6] and 
strempeliopine (2)[7] have been completed. Heathcock’s 
ingenious landmark racemic synthesis of vallesamidine (1) was 
completed in 8 steps in 19% overall yield.[6a,b] Asymmetric variants 
have relied upon formal syntheses[6c,d] from this, or new 
approaches[6e,f,h] and all vary in length from 15-23 steps. 
Strempeliopine (2) has been prepared using biomimetic[7a], 
racemic[7c] and asymmetric multi-step syntheses[7d] in similar step 
count. In all of these elegant approaches the opportunity to enable 
a divergent synthesis to the structurally related schizozygine 
alkaloids is denied because the C-14,15 single bond was present 
from the beginning and it would be synthetically challenging to 
introduce the required C-14,15 double bond. Hájíček and co-
workers reported a study on 14,15-dehydrostrempeliopine (6), a 
model towards schizozygine (3), through a 15-hydroxyl 
precursor, but the final dehydration failed.[8] We report here a 
distinctive synthetic strategy towards the schizozygine alkaloids 
based on a synthetically valuable late stage C-14,15 alkene 
divergent intermediate 7 (Scheme 1). Notable aspects of our 
synthesis include a novel [1,4]-hydride transfer/Mannich 
cyclisation, the exploitation of the nitro functional group for the 
synthesis of 3 of the 5 rings, the demonstration of a 
diastereoselective ring closing metathesis and the gram-scale 
synthesis of late stage intermediates in high stereoselectivity and 
yield. We show the divergence of this route by the total synthesis 
of (+)-vallesamidine (1) and (+)-14,15-dehydro-strempeliopine (6) 
in 2-3 simple transformations. Compound 6 is skelatally identical 
to schizozygine (3).[9] The strategy could deliver other 
schizozygine alkaloids 3-5 and we demonstrate the synthesis of 
analogous unnatural  structures.  
 
 
Figure 1. vallesamine and schizozygine alkaloids 
 
Retrosynthetically access to both targets 1 and 6 would be 
by forming ring D by a diastereoselective ring closing 
metathesis[10a-c,g] of 8 to a common intermeduate 7 (Scheme 1). 
The bis-C-20 vinyl substituents would be derived from malonate 
9. For the formation of ring E we proposed a novel [1,4]-hydride 
transfer (HT)/Mannich cyclisation on the piperidine ring C of 10. 
The synthesis of the precursor to this (11) relies upon the diverse 
chemistry of the nitro functional group and was guided by our 
studies on the stereoselective nitro-Mannich reaction[11] and the 
formation of indolines from the chemoselective cyclisation of 1,2-
diamines.[12] The precursor to ring B (12) bearing a quaternary 
carbon (C-2) would be prepared through a Tsuji-Trost allylation of 
nitro lactam 13, a known skeleton that could be assembled 
through nitro-Mannich/ lactamisation cascade from nitro malonate 
14.[13] Asymmetry would be introduced by an enantioselective 
Michael addition on nitro alkene 15 and the diastereoselectivity of 
the subsequent nitro-Mannich reaction dictated by the chiral 
centre formed.[14]   
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Scheme 2. [1,n]-HT/cyclisation strategy of piperidines 
 
The [1,n]-hydride transfer (HT)/cyclisation, also regarded as 
an internal redox neutral C-H functionalisation, is an unusual 
method for ring formation that has been recently developed for 
more complex systems[15] since the first examples that were 
classified under the term the ‘tert-amino effect’[16] (Scheme 2). In 
this transformation, the conformational requirement for hydride 
donor and acceptor in a spatially closed relationship is crucial and 
thus substrate scopes are still limited. Based on our 
retrosynthesis a [1,4]-HT/cyclisation on a 3-substituted piperidine 
was proposed to construct the C/E bicyclic skeleton and install the 
C-20 quaternary centre. Currently there have been very few 
reports of [1,4]-HT/cyclisation reactions and all of these involved 
benzylic C-H bonds.[17] The work by Sames[18] and Saá[19] 
disclosed the [1,6] and [1,5]-HT/cyclisation on 3-substituted 
piperidines with alkynes as hydride acceptors and these 
impressive results indicated the stereochemical requirements and 
possibilities for applying the [1,4]-HT/cyclisation on piperidines.  
Results and Discussion 
The total synthesis of (+)-vallesamidine (1) and (+)-14,15-
dehydrostrempeliopine (6) commenced with the asymmetric 
Michael addition of diethyl malonate to 2-bromonitrostyrene 15 
using chiral nickel (II) complex 16, developed by Evans et al, as 
the catalyst.[20] The ease of catalyst preparation and mild 
conditions made the reaction scalable and the enantioselectivity 
of adduct 14 could be maintained at 95:5 er at 20 grams scale. 
The nitro-Mannich/lactamisation cascade was followed by 
Krapcho decarboxylation of the crude reaction mixture to give the 
nitro lactam 13 in 84% overall yield in ~5:1 dr at C-2. The 
diastereoselectivity was immaterial as subjection of the mixture to 
a palladium catalysed Tsuji-Trost allylation to introduce the C-2 
quaternary centre stereoselectively (13-a) and the allylated 
product 12 was obtained in 86% yield with 95:5 dr. Reduction of 
the nitro group with Zn/HCl provided the free amine quantitatively 
and the crude product was directly used in the intramolecular C-
N coupling reaction. The palladium catalysed C-N coupling 
reaction (Pd(PPh3)4/t-BuONa/PhMe)[12] was attempted first and 
the desired indoline 17 was obtained in 65% yield. Ligand free 
Ullmann type coupling using cheaper CuI catalyst only gave 56% 
conversion and 40% yield and increasing the catalyst loading from 
5 mol% to 10 mol% improved the yield to only 55%. The moderate 
yield of this clean reaction led us to consider adding ligands to 
accelerate the progress.[21] We first tested Ma’s conditions[22] 
using commercial proline as ligand and it significantly shortened 
the reaction time to 1 h and improved the yield of crude indoline 
to 94% without further purification (see SI for spectral comparison). 
Protection of the free indoline in neat methyl chloroformate gave 
11 in 86% yield over three steps from 12.[23]   
 
Scheme 3. Synthesis of ABC ring intermediate 11. Conditions: a) 
diethylmalonate, cat. 16 (1.0 mol%), PhMe, rt, 72 h, 80%; b) PMBNH2, (HCHO)n, 
EtOH, 80 oC, 2 h; c) NaCl, DMSO, 160 oC, 16 h, 84% from 14; d) Pd(PPh3)4 (1.0 
mol%), allyl acetate, DBU, CH2Cl2, 0 oC, 30 min, 86%; e) Zn dust, 6 M HCl aq., 
EtOH/EtOAc, 0 oC, 1 h, quant.; f) CuI (10 mol%), L-proline (20 mol%),  K3PO4 
(2.0 eq.), DMSO, 80 oC, 1 h; g) ClCO2Me (neat), 65 oC, 16 h, 86% from 12. 





PMBNH2 = p-methoxybenzylamine; DMSO = dimethylsulfoxide; DBU = 1,8-
diazabicyclo [5.4.0]undec-7-ene.   
 
Ring E was formed using a [1,4]-HT/Mannich cyclisation 
(Scheme 4). The expected challenges for the desired hydride 
transfer/cyclisation were the accessibility of the necessary 
reactive conformation for hydride transfer and good affinity 
between the Lewis acid and malonate motif over the basic 
piperidine nitrogen atom. Normally a basic amine would 
sequester the Lewis acid and prohibit the hydride 
transfer/cyclisation to occur, presumably why most hydride 
transfer/cyclisation substrates are aniline type structures. From 
an inspection of the likely conformation of our desired precursor 
10 we speculated that the correct stereoelectronic geometry could 
be easily obtained and that the steric complexity around the 
piperidine nitrogen could inhibit coordination of a Lewis acid. To 
this end piperidine 18 was obtained in high yield by 
chemoselective reduction via an in situ thionium ion formed by 
sequential treatment of lactam 11 with Lawesson’s reagent, MeI 
and NaBH4. The oxidative cleavage of the allyl group in 18 was 
initially problematic either with ozonolysis or OsO4/NaIO4 
conditions, probably due to the oxidation sensitive piperidine 
nitrogen. Protonation of the basic piperidine nitrogen with 
trifluoroacetic acid acted as in situ protection, which upon 
ozonolysis, smoothly gave the aldehyde in 90% yield.[24] In 
preparation for the late stage ring closing metathesis to form ring 
D, the PMB group had to be removed and changed to the allyl 
group. Therefore, treatment of the aldehyde with allyl 
chloroformate yielded the allyl carbamate 19 in an acceptable 
yield of 56% (77% brsm). Increasing the reaction time slightly 
improved the yield but the starting material could not be fully 
converted. Based on the conformation of the aldehyde, we 
suggest that hyperconjugation between the nitrogen lone pair 
orbital and * orbital of the aldehyde[25] inhibits the nucleophilicity 
of the piperidine amine and accounts for the slow, incomplete 
functional group interconversion. To explore this hypothesis and 
increase the efficiency of the PMB/allyl group exchange, 
dioxolane compound 21 was prepared through oxidative cleavage 
of alkene 11,[26] followed by aldehyde protection and catalytic 
amide reduction.[27] The reaction of 21 with allylchloroformate was 
significantly improved with complete conversion, a shorter 
reaction time (1 h) and reduced reagent usage (10.0 eq. to 5.0 eq. 
of allylchloroformate). The crude product, after removal of any 
volatile species, was subjected to acidic hydrolysis directly and 




Scheme 4. Synthesis of ABCE ring intermediate 9 through [1,4]-hydride transfer/Mannich cyclisation. Conditions: a) Lawesson’s reagent, PhMe, 80 oC, 1 h, 93%; 
b) MeI, reflux, 2 h, then NaBH4, MeOH, 0 oC, 1 h, quant.; c) TFA, 0 oC, CH2Cl2, 10 min, then O3, CH2Cl2, -78 oC, then Me2S, -78 oC to rt, 90%; d) allyl chloroformate, 
DCE, 75 oC, 48 h, 56%; e) Pd(PPh3)4 (2.5 mol%), CH2Cl2, rt, 1 h, 92%; f) dimethyl malonate, L-proline, DMSO, rt, 24 h, 96%; g) Yb(OTf)3 (10 mol%), PhMe, reflux, 
80%; h) OsO4 (2 mol%), NMO, 2,6-lutidine, acetone-H2O, 24 h, then PhI(OAc)2 0.5 h, 78%; i) (CH2OTMS)2, TMSOTf (10 mol%), CH2Cl2, -78 oC to rt, quant; j) 
Mo(CO)6 (10 mol%), PhSiH3, THF, 65 oC, 8 h, 76% over 2 steps; k) allylchloroformate, NaHCO3, DCE, 80 oC, 1 h, then AcOH, THF-H2O, 90 oC, 24 h, 72% from 21. 
Lawesson’s regent = 2,4-Bis(4-methoxyphenyl)-2,4-dithioxo-1,3,2,4-dithiadiphosphetane; TFA = trifluoroacetic acid; DCE = 1,2-dichloroethane. 
 
Subsequent treatment of allyl carbamate 19 with catalytic 
Pd(PPh3)4 triggered the decarboxylative allylation to give 20 and 
Knoevenagel condensation with dimethyl malonate afforded the 
-unsaturated malonate 10, the precursor for the [1,4]-
HT/Mannich cyclisation again in high yields. To our satisfaction, 
treatment of 10 with catalytic Yb(OTf)3 in reflux toluene promoted 
the desired [1,4]-hydride transfer/Mannich cyclisation cleanly to 
give the ABCE ring intermediate 9 in 80% yield for the efficient 
formation of the second quaternary centre. The relative 
stereochemistry was confirmed by a NOESY experiment. This 
unique transformation provided a good example of ring 
construction in alkaloids synthesis and may find potential 
application in the synthesis of other complex molecules.  
Manipulations to form the metathesis precursor 8 for the 
formation of the ring D began with the chemoselective reduction 
of malonate 9 to the corresponding diol under optimised 
conditions (LiAlH4, room temperature, 15 min) (Scheme 5). A 
concise route to 8, based on Feldman’s work,[10a,c] was to oxidise 
the diol to dialdehyde, followed by Wittig reaction to give dialkene 
8. However, degradation was observed during the oxidation and 
no appropriate conditions could be found. Therefore a sequential 
olefination sequence was necessary and began with the selective 





mono-protection of the diol on the sterically less hindered hydroxyl 
group in 51% yield from 9. Oxidation of the remaining alcohol 
using IBX in EtOAc[28] gave the aldehyde 22 quantitatively but with 
epimerisation at C-20 (~1:1), either from silyl exchange before 
oxidation or Mannich type retro ring opening/re-cyclisation. 
Fortunately, simple treatment of the epimers with silica gel in 
dichloromethane led to the nearly diastereomerically pure desired, 
thermodynamically more stable isomer 22 (93:7). The Petasis 
olefination was applied on hindered aldehyde 22 and the crude 
alkene was treated with TBAF to give 23 in 65% yield. Ultimately, 
the trialkene intermediate 8 was obtained in good yield after a 
Swern oxidation and Wittig olefination sequence. A 
diastereoselective ring closing metathesis was then performed 
and the ring D cyclised product 7 was isolated as a single 
diastereomer in 76% yield.   
The ABCDE ring intermediate 7 represents a divergent 
intermediate from which vallesamidine, strepeliopine and 
schizozygine type alkaloids can be prepared. For example 7 was 
subjected to LiAlH4 reduction to give dehydrovallseamidine 24 
and catalytic hydrogenation proceeded uneventfully to give (+)-
vallesamidine (1), the spectral data of which were consistent with 
literature data.[6] For the preparation of 14,15-dehydro-
strempeliopine (6), that possesses the same skeletal features as 
schizozygine (3), regioselective hydroboration/oxidation[30] of 7 
was performed first to provide primary alcohol 25. Hydrolysis of 
the carbamate followed by oxidative cyclisation gave 6 and the 
spectral data of the core skeleton was in agreement with that of 
schizozygine (1).[31]  
 
Scheme 5. Synthesis of divergent intermediate 7 and total synthesis of (+)-
vallesamidine (1) and (+)-14,15-dehydrostrempeliopine (6). Conditions: a) 
LiAlH4, THF, 0 to 22 oC, 15 min; b) TBDPSCl, Et3N, DMAP, CH2Cl2, 51% from 
9; c) IBX, EtOAc, reflux, 2 h, then silica gel, CH2Cl2, 2 h; d) Cp2TiMe2, PhMe, 80 
oC, simple work-up, then TBAF, THF, 70 oC, 3 h, 65% from IBX oxidation; e) 
(COCl)2, DMSO, Et3N, CH2Cl2, -78 to 0 oC, simple work-up, then Ph3PCH3Br, 
NaHMDS, THF, -78 oC to rt, 76%; f) Hoveyda-Grubbs 2nd catalyst (10 mol%),[29] 
PhMe, 80 oC, 1.5 h, 76%; g) LiAlH4, THF, 0 to 65 oC , 30 min, 80%; h) Pd/C, H2, 
MeOH, rt, 3 h, 77%; i) c-Hex2BH, then NaBO3.H2O, THF; j) 6M KOH aq., MeOH, 
100 oC, 16 h; k) TPAP (10 mol%), NMO, CH2Cl2, 30 min, 34% from 7.  THF = 
tetrahydrofuran; Im = imidazole; IBX = 2-Iodoxybenzoic acid; Cp = 
cycopentadienyl; Hoveyda-Grubbs 2nd catalyst = (1,3-Bis-(2,4,6-
trimethylphenyl)-2-imidazolidinylidene)dichloro(o-isopropoxy-phenyl-
methylene) ruthenium; TBAF = tetra-n-butylammonium fluoride. 
 
 As an example of the opportunities this divergent route 
opens for the synthesis of unnatural analogues of the 
schizozygine alkaloid family, we isolated two new structures 
during our studies towards the synthesis of 14,15-dehydro-
strempeliopine (6) (Scheme 6). Treatment of 23 with 
methanesulfonyl chloride gave the mesylate 26 in quantitative 
yield. After ring closing metathesis to 27, attempted displacement 
of the mesyl group with KCN in DMSO at 100 oC gave two new 
products 28 (32%)and 29 (31%).These represent key molecules 
for SAR studies around the importance of the lactam function of 
the schizozygine alkaloids for biological activity. 
 
Scheme 6. Manipulation of alcohol 23 and preparation of unnatural analogues 
28 and 29. Conditions: a) MsCl, Et3N, CH2Cl2, 0 oC to rt, 1.5 h, quant.; b) 
Hoveyda-Grubbs cat. (10 mol%), PhMe, 80 oC, 4 h, 80%; c) KCN, DMSO, 100 
oC, 16 h, 28 32% and 29 31%. Ms = methanesulfonyl. 
Conclusion 
In conclusion, an efficient, high yielding and selective 
asymmetric synthetic route to a late stage C-14,15 alkene 
divergent intermediate 7 that could be simply transformed into (+)-
vallesamidine (1) and (+)-14,15-dehydrostrempeliopine (6) has 
been realised. Although the step count of this synthetic approach 
(23 steps to vallesamidine) is slightly higher than other 
asymmetric routes to inidividual alkaloids of this family, such as 
vallesamidine, our route only required 14 chromatographic 
purifications and we have shown its valuable and unique synthetic 
diversity to other natural and unnatural structurally related 
strempeliopine and schizozygine alkaloid skeletons. The route is 
flexible in terms of absolute stereochemistry, the opportunity for 
more functionalised aromatic cores in the Michael reaction of the 
starting nitro alkene 15 and other late stage synthetic 
manipulations. The synthesis makes good use of simple 
nitroalkane/alkene chemistry, including Michael addition, nitro-
Mannich/ lactamisation, Tsuji-Trost allylation and nitro-
reduction/C-N coupling reaction, to quickly generate complexity in 
the A/B/C ring skeleton in high yield and gram scale. A novel and 
high yielding Lewis acid catalysed [1,4]-hydride transfer/Mannich 
type cascade cyclisation was used to construct ring E in gram 
scale. This C-H functionalisation reaction should be highly useful 
for the synthesis of other complex molecules. The successful 
installation of the key C-14,15 double bond in ring D was achieved 





through a diastereoselective ring closing metathesis. We are 
using this divergent route for the synthesis of similar alkaloid 
targets for the investigation of their biological activity. 
 
Experimental Section 
Experimental details, compounds characterisation data and spectra are 
attached in supporting information. 
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Necessity is the mother of invention and never more so than in target synthesis. The 
total synthesis of (+)-vallesamidine and (+)-14,15-dehydrostrempeliopine were 
achieved from a common intermediate that is related to other alkaloids and 
necessitated the development of a novel [1,4]-hydride transfer/Mannich cyclisation to 
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